insider24.ch
Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

inSanthera Pharmaceuticals Holding AG

Declared position

75.87%

Threshold

Crossed downwards

Timeline

Published

26.07.2023

Transaction

18.07.2023

Voting rights breakdown

Voting rights acquired15.91%
Voting rights sold75.87%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAN7K00035

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Vollzug der am 19.06.2023 gemeldeten Aktienübertragung Regarding certain sale positions

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open